Pharmacokinetics and Safety of Duloxetine, a Dual‐Serotonin and Norepinephrine Reuptake Inhibitor
Year: 2000
Type: article
Study design: Clinical Trial
Institution: Eli Lilly (United States)
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Keywords: duloxetine, pharmacokinetics, drug safety, serotonin-norepinephrine reuptake inhibitors, multiple-dose regimen, dose escalation, oral clearance, volume of distribution, half-life, blood pressure, heart rate, abrupt discontinuation, sleep disorders, linear pharmacokinetics, healthy volunteers
Open Access status: closed
OpenAlex ID: W2072772870
